Navigation Links
Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund
Date:11/13/2012

SALT LAKE CITY, Nov. 13, 2012 /PRNewswire/ -- Remedy Informatics, Inc., the leader in registries for healthcare and life science research, announced today that the Merck Global Health Innovation Fund (GHIF) has made an investment of growth capital in the company. The investment of roughly $6 million includes a seat on Remedy's Board of Directors and the opportunity for additional investments in the future.

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

"In the past year we've experienced unprecedented demand for our registries and integrated research management systems. This additional capital will fuel our growth here in the U.S. and our expansion into Europe and Latin America," said Gary Kennedy, Founder & CEO of Remedy Informatics. "In addition it will enable us to continue to invest in our Mosaic™ Platform so that we can further extend our technology lead in the marketplace."

Remedy serves a wide range of leading life science and healthcare institutions across the globe. During the last 12 months Remedy has entered into a series of major new customer engagements, including Cleveland Clinic's Heart and Vascular Institute, Massachusetts General Hospital, Baylor Health Care System, Princess Margaret Cancer Centre in Toronto, Indiana University and the Indiana Clinical and Translational Science Institute, Genentech and many others. Remedy's Investigate™ integrated research management system provides game-changing new capabilities for researchers in translational science by integrating data flows and analytics across the lab, clinic and biobank settings. Remedy has also deployed powerful new clinical registries like ComprehensiveOncology™ (suite of solid tumor and blood cancer registries), ComprehensiveBMT™ (blood and marrow transplant registry), RemedyJoint™ (total joint replacement registry), and many others that enable tracking of patient outcomes and conducting clinical research.

"Healthcare information technology is a key area of focus for Merck's Global Health Innovation Fund," said Joe Volpe, investment principle for GHIF. "We believe Remedy's technology platform is well positioned to help advance life science research discoveries."

About Remedy Informatics, Inc.

Remedy Informatics, Inc. is the leading provider of clinical registries, medical research software, and research informatics products that accelerate translational medicine discoveries from bench to bedside. Remedy offers a wide range of configurable "off the shelf" biomedical informatics products that are built on the powerful Mosaic™ Platform. Remedy's mission is to tangibly, measurably and permanently improve the effectiveness of Life Science Research in the United States and across the globe.  For more information visit: www.remedyinformatics.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Gary Kennedy
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106824

Media Contacts
Kristofer Beldin, Remedy Informatics, (801) 870-9407 (cell), kris.beldin@remedyinformatics.com

 


'/>"/>
SOURCE Remedy Informatics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Remedy Informatics Joins LongView International Technology Solutions Team to Win CIO-SP3 Contract Award
2. The Jewish Hospital - Mercy Health Selects Remedy Informatics ComprehensiveBMT Product
3. Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting
4. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
5. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
6. Frost & Sullivan: U.S. Medical Imaging Informatics Industry Reconnects with Growth in the Enterprise Image Archiving Market
7. Frost & Sullivan Acknowledges the Value Dell Healthcare and Life Sciences Brings to the Enterprise Imaging Informatics Marketplace
8. Pharma IQs Laboratory Informatics Whitepaper
9. Health Revenue Assurance Associates Hires Valerie Rinkle as Vice President of Revenue Integrity Informatics
10. Pharma IQs Laboratory Informatics Report: Current Trends & Predictions for 2015
11. RPS Announces Jonathan M. Fishbein, MD as Executive Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):